Evidence map›Paper›PMID 38782400›Full record

ArticleHuman vaccines & immunotherapeutics2024

COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population.

Narmeen Mallah, Jacobo Pardo-Seco, Irene Rivero-Calle, Ouhao Zhu-Huang, María Fernández Prada, Catharina Reynen-de Kat, Oleg Benes, Liudmila Mosina, Siddhartha Sankar-Datta, Olga Aleksinskaya and 8 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Narmeen MallahGenetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Jacobo Pardo-SecoGenetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Irene Rivero-CalleGenetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
Ouhao Zhu-HuangGenetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.
María Fernández PradaServicio de Medicina Preventiva y Salud Pública, Hospital Vital Álvarez Buylla, Asturias, Spain.
Catharina Reynen-de KatWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Oleg BenesWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Liudmila MosinaWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Siddhartha Sankar-DattaWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Olga AleksinskayaEnglish-Russian medical interpreter/translator, Russian Federation.
David DíazHead of Design and Development Marketing agency, Sisuco Solutions, Madrid, Spain.
Vusala AllahverdiyevaWorld Health Organization Country Office in Ukraine, Kyiv, Ukraine.
Yevgenii GrechukhaWorld Health Organization Country Office in Ukraine, Kyiv, Ukraine.
Tamara JobavaDigital Marketing Consultant & Project Manager, World Health Organization, Georgia.
Mariia SavchynaWorld Health Organization Country Office in Ukraine, Kyiv, Ukraine.
Pavla KortusovaWorld Health Organization Country Office, Czechia.
Ioana NovacWorld Health Organization Country Office, Bucharest, Romania.
Federico Martinón-TorresGenetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain.ORCID 0000-0002-9023-581X

Funding

World Health Organization 001
6 · The paper itself

Abstract

COVID-19 vaccine uptake varied across countries, in part due to vaccine hesitancy fueled by a lack of trustworthy information. To help health workers provide evidence-based answers to common questions about COVID-19 vaccines and vaccination, and thereby, assist individuals´ decisions on vaccine acceptance, COVID-19 InfoVaccines, a joint WHO-EU project, was launched in February 2021 to support COVID-19 vaccine rollout in 6 Eastern European countries. COVID-19 InfoVaccines was made available in seven languages and shared on social media networks. A total of 262,592 users accessed COVID-19 InfoVaccines.com between February 11, 2021, and January 31

Indexed as

COVID-19COVID-19 VaccinesSocial MediaVaccinationAdultFemaleHealth EducationHealth PersonnelHumansMaleSARS-CoV-2Vaccination HesitancyWorld Health OrganizationCOVID-19 VaccinesCOVID-19COVID-19 InfoVaccineseducational toolEuropemisinformationvaccinevaccine hesitancyWorld Health Organization

Identifiers

PMID38782400
PMCPMC11123498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.